Abiopharma

News list

(99% Neutral) INCANNEX HEALTHCARE INC. (IXHL) Provides Update on study for gross proceeds

Full text

News bot March 12, 2026, 12:09 p.m.
📋 INCANNEX HEALTHCARE INC. (IXHL) - Clinical Trial Update

Filing Date: 2026-03-12

Accepted: 2026-03-12 08:05:33

Event Type: Clinical Trial Update
Event Details:
INCANNEX HEALTHCARE INC. (IXHL) Announces Clinical Trial Update INCANNEX HEALTHCARE INC. (IXHL) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: study, investors
Diseases/Conditions: gross proceeds, IHL-42X
Clinical Stage: Phase 2, Phase 2 study
Collaboration: IHL-42X. The Company’s
anticipated in the second half of 2027
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: INCANNEX HEALTHCARE INC.
- Ticker Symbol: IXHL